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Resection of carotid body tumors (CBTs) has
long been considered a surgical challenge. Initial
attempts at surgical resection of these paragangliomas
were associated with mortality and morbidity rates of
30% and 40%, respectively, leading some surgeons to
consider nonoperative treatment.1-4 Although subse-
quent advances in preoperative evaluation, surgical
technique, and intraoperative monitoring of these
patients have reduced the mortality to nearly zero, the
incidence of neurologic complications has remained
significant, varying between 10% and 40%.5-12
Nonetheless, because of their locally invasive nature
and the uncertainty about their natural history, surgi-
cal resection of a CBT as soon as the diagnosis is
established has been recommended.6,12-16
Advances in imaging technologies have resulted
in earlier detection of these neoplasms, some of
which are less than 2 cm in diameter. The discovery
of such smaller CBTs has resulted in a therapeutic
dilemma with respect to their management. Does
their incidental finding still warrant an aggressive
surgical approach, irrespective of their size?
To analyze the impact of newer imaging modal-
ities on the detection of CBTs and their influence
on the management of these uncommon lesions, we
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reviewed the experience at our institution and affil-
iated regional hospitals over the past 16 years. Our
goal was to compare two groups of patients with
CBTs: those with tumors discovered by palpation
(designated Group 1), and those whose tumors
were first identified by duplex scanning or through
some other imaging modalities (designated Group
2) during diagnostic work-ups for the presence of
local symptoms or other associated diseases.
METHODS
The medical records of patients diagnosed with
CBTs between 1981 and 1997 at a number of teach-
ing hospitals affiliated with the University of Arizona,
the Good Samaritan Hospital of Phoenix, and the
Mayo Clinic/Scottsdale were reviewed. Information
was obtained by direct communication with surgeons
at these medical facilities who had experience treating
CBTs during the study period. In addition to the
practitioners’ data files, hospital records were con-
sulted when they were available. Two groups of
patients were identified on the basis of the mode of
detection of their tumor: Tumors discovered on
physical examination were classified as Group 1,
whereas those found incidentally on duplex scanning,
computed tomography (CT), or magnetic resonance
imaging (MRI) were classified as Group 2. One 2-cm
tumor was found incidentally at autopsy and exclud-
ed from further analysis. Tumor size, the use of pre-
operative embolization, the incidence of neurologic
complications (stroke, cranial nerve injuries), recur-
rence, and metastasis were noted for each group. The
Shamblin classification was used to assess the difficul-
ty of surgical resection: class 1 lesions consisted of
tumors easily isolated and dissected from the carotid
vessels; class 2 CBTs were more adherent to the
adventitial layer and partially encircled the vessels at
the bifurcation; and class 3 lesions were densely
adherent to the carotid vessels and completely encir-
cled the carotid bifurcation.17
RESULTS
Over the 16 years of this study, 31 patients with
a total of 32 CBTs were available for review. Of these
patients, 15 were men and 16 were women, and the
mean age was 48 years (range, 32-90 years). Ten
tumors were located on the right side and 22 on the
left; one patient had bilateral chemodectomas. Co-
morbid conditions are listed in Table I.
In Group I (n = 23), the presence of a neck mass
had prompted the patient to seek medical attention
in 18 instances; 5 tumors in Group I had been dis-
covered on physical examination by a physician. No
exact information could be obtained regarding the
time interval between the initial discovery of the mass
and the subsequent operative management. In Group
2 (n = 9), the tumors were first detected through use
of an imaging modality; eight of these tumors were
discovered incidentally on duplex scanning (Fig. 1)
performed to rule out carotid artery occlusive disease
or vertebrobasilar insufficiency, and one tumor was
first detected on MRI during evaluation of a palpable
contralateral CBT. Tumor size was determined by
physical examination in 15 of 23 patients in Group I
and by duplex scanning in the remaining 8 patients.
There appeared to be a good correlation between val-
ues obtained clinically and measurements of the
pathologic specimens. The mean size of the CBTs in
Group 1 was 4.3 ± 1.7 cm; this compares with 2.7 ±
1.0 cm for Group 2 (p = 0.007, by paired t test).
None of the patients in either group manifested pre-
operative focal neurologic symptoms. All neurologic
complications occurred in the perioperative period
and were related to preoperative embolization, intra-
operative manipulation of the carotid artery, or injury
to adjacent cranial nerves.
Preoperative evaluation and management
Imaging modalities performed included duplex
scanning (9), CT (4), and MRI (2). A cerebral
angiogram was obtained in all cases before surgery
(Fig. 2), with the exception of one patient who had
CT angiography (Fig. 3). Preoperative embolization
was performed at the discretion of the surgeon in six
Group I patients (mean tumor size before emboliza-
tion, 5 cm; range, 4.3-6 cm) and no patients in
Group 2. Obliteration of the microvasculature of the
CBTs was felt to be successful in five cases on the
basis of completion studies. In one instance the pro-
cedure was terminated prematurely when the patient
complained of an acute ipsilateral visual deficit.
Operative procedure
The patient is positioned supine, with the neck
rotated to the opposite side. Because the need for
carotid resection cannot always be predicted, one leg
is prepared in all procedures in case the saphenous
vein should be required.
Table I. Co-morbid conditions
Condition n (%)
Hypertension 12 (38.7%)
Diabetes Mellitus 3 (9.6%)
Coronary Artery Disease 4 (12.9%)
Peripheral Vascular Disease 3 (9.6%)
Previous Stroke 3 (9.6%)
Smoking History 13 (41.9%)
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Fig. 1. Color flow doppler of carotid vessels shows presence of (A) small carotid body tumor
and (B) large CBT at bifurcation.
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The carotid artery is exposed through a standard
anterolateral cervical incision along the anterior bor-
der of the sternocleidomastoid muscle. Control of
the common, internal, and external carotid arteries
is obtained, and the hypoglossal and vagus nerves
are identified. Through use of bipolar diathermy a
dissection plane is established at the inferior margin
of the tumor at the bifurcation and extended cepha-
lad onto the internal and external carotid arteries.
Branches of the external carotid artery may require
division to facilitate the dissection. This technique is
usually adequate for excision of Shamblin 1 and 2
CBTs. Tumors completely encasing or infiltrating
the internal carotid artery (class 3) are often man-
aged by resection of the involved portion of the
artery and replacement with a saphenous interposi-
tion vein graft. It may be necessary to mobilize the
parotid gland and divide the digastric and stylohyoid
muscles to facilitate exposure for tumors extending
to the base of the skull.
Operation on patients who had undergone preop-
erative embolization was usually undertaken within
24 to 48 hours. At surgery, 10 tumors were classified
as Shamblin class 1, 15 as class 2, and 6 as class 3
(Table II). An indwelling carotid artery shunt placed
through the vein graft was used to facilitate the distal
anastomosis in three instances. Complete excision of
the tumor was accomplished in 29 of 31 cases.
Residual tumor was present in each of two Group 1
cases because the operating surgeon believed that the
extensive resection required to remove all obvious
tumor was not justified. The external carotid artery
was ligated in nine cases, and internal carotid artery
reconstruction (seven nonreversed saphenous inter-
position veingrafts and one expanded polytetrafluo-
roethylene patch angioplasty) was needed in eight
cases (Table II). One patient received a 1-unit trans-
fusion of red blood cells.
No perioperative mortality was observed in
either group. The average postoperative follow-up
was 3.2 years.
Neurologic complications
In Group 1, one patient had a stroke after preop-
erative embolization; a second patient had a postop-
erative aphasia, presumably because of embolization
from unrecognized carotid disease that partially
resolved. Three patients sustained cranial nerve
injuries during resection of their tumors: injury to the
mandibular branch of the facial nerve was observed in
one of these three patients, resection of segments of
the IX, X, and XII cranial nerves was necessary to per-
mit complete removal of an invasive neoplasm in
another, and injury to the hypoglossal nerve occurred
in the third. This last patient subsequently underwent
radiation therapy, but the tumor recurred in 1993 and
has extended to the base of the skull with metastasis
to the brain, which has resulted in multiple cranial
nerve palsies. This was the only case in our series in
which a definite proof of malignancy could be estab-
lished because of the presence of metastasis.
In Group 2, one patient sustained an injury to
the hypoglossal nerve during excision of a 4 · 3-cm
CBT that, despite its size, had been missed on clini-
cal examination and was first diagnosed by duplex
scanning.
DISCUSSION
Carotid body tumors are uncommon lesions.
Since the report by Marchand18 in 1891, there have
Fig. 2. Cerebral angiogram showing tumor blush and
characteristic splaying of the bifurcation of the internal
and external carotid arteries.
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been a number of sporadic reports in the literature.
Approximately 1000 cases had been reported by
1990.19 The Mayo Clinic reported one of the largest
series to date, describing 153 cases over a 50-year
period.6 Carotid body tumors are seen in most series
with roughly the same frequency in male and female
patients; they primarily occur in the fifth decade of
life, although studies of CBTs occurring at high alti-
tude have noted a marked predilection for female
patients.20 Cases can be sporadic or familial; in famil-
ial series, they are often bilateral—either synchro-
nous or metachronous—and may be associated with
other paragangliomas as well as coagulation disor-
ders.21 All of the cases evaluated in this study were
sporadic and had no apparent relationship to high
altitude. Macroscopically CBTs usually have a meaty,
light tan appearance, but they may appear congested
or frankly hemorrhagic as a result of surgical manip-
ulation. Necrosis is usually rare except after success-
ful preoperative embolization. Histologically the
Fig. 3. A CT angiogram shows large chemodectoma at carotid bifurcation.
Table II. Comparison of operative procedures and morbidity between groups
Shamblin 
Complete tumor Cranial nerve
classification
resection ECA ligation ICA reconstruction Injuries StrokeClass n
Group 1 (n = 23)
1 6 21 9 8 3 2
2 11
3 6
Group 2 (n = 8)  
(+ 1 CBT being followed) 1 4 8 0 0 1 0
2 4
3 0
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most characteristic feature of these lesions is the uni-
form nesting arrangement of the cells. Most of the
cells present are chief cells containing neurosecreto-
ry granules, with sustentacular cells and a vascular
stroma comprising the remainder of the tumor (Fig.
4). However, most CBTs appear to be nonsecret-
ing.22 Earlier histologic studies23 based on mitotic
activity, capsular invasion, and cellular pleomor-
phism suggested that up to 50% of these 10 lesions
were malignant. More recent studies5,24-26 have esti-
mated the incidence of malignancy to be between
5% and 10%. Aggressive local invasion with encir-
Fig. 4. Histologic features of CBT. A, Typically uniform nesting arrangement of cells (hema-
toxylin-eosin, magnification · 25). B, Immunohistochemistry shows reactivity for chromo-
granin A (magnification · 200).
clement of the carotid vessels may suggest the pres-
ence of a cancerous lesion; however, documentation
of metastasis to regional lymph nodes, liver, or lungs
is usually required for a CBT to be designated as
malignant.
Lack of preoperative diagnosis has been reported
in up to 30% of patients20 with CBTs. The usual pre-
sentation is a slow-growing mass at the angle of the
mandible. Sometimes these tumors are confused
with enlarged lymph nodes, branchial cysts, salivary
glands, carotid aneurysms, or neurofibromas, and
the patients are consequently subjected to unwise
attempts at biopsy or exploratory surgery. Two
patients in this study underwent preoperative biop-
sies: one had a fine-needle biopsy suggestive of
malignancy and the other had an open biopsy rapid-
ly terminated because of excessive bleeding. The
presence of a symptomless mass in the anterior tri-
angle of the neck should alert the examiner to the
possibility of a CBT. A useful clinical sign in differ-
entiating a CBT from other lesions is Fontaine’s
sign: a carotid body tumor can usually be displaced
laterally but not vertically. Lateral displacement
results in movement of the common carotid pulse in
the same direction as the tumor.
The advent of new imaging technologies poten-
tially allows the detection of CBTs at an earlier stage,
before they become palpable. In our study, tumors
first detected on imaging studies were statistically
smaller (4.3 vs 2.7 cm) than those detected on phys-
ical examination. Eight of the tumors were first dis-
covered incidentally by duplex imaging in 11
patients being evaluated for carotid artery occlusive
disease. Several small series have now reported
improved sensitivity and specificity of duplex ultra-
sound in identifying CBTs.16,27-31 Typical features
include the presence of a solid hypoechoic vascular
mass that on Doppler frequency analysis may show a
low-resistance arterial flow pattern.16 In our series,
B-mode imaging with color flow Doppler of the
carotid vessels first identified a tumor at the carotid
bifurcation in eight cases (Fig. 1). This imaging
modality may allow exclusion of other tumorous or
vascular entities that could be mistaken for carotid
body tumors; the performance of ill-advised biopsy
procedures could thus be avoided.12
Duplex scanning currently appears to be the
most useful screening test both in sporadic and
familial cases for early detection and diagnostic con-
firmation of the presence of CBTs. CT or MRI scans
are useful in assessing the extent of the neoplasm, its
relationship with the carotid arteries and adjacent
structures, and the presence of metastases. Although
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conventional angiography yields a characteristic
appearance (Fig. 2), its routine use may be limited in
the future to those patients with indeterminate find-
ings on duplex scan, CT, or MRI and aimed at pro-
viding access for preoperative embolization, if the
surgeon so elects. All but one of the patients in our
series had cerebral angiograms; in the remaining
patient, both carotid arteries and the tumor were
clearly delineated on CT angiogram (Fig. 3), which
allowed surgical resection without angiography.
Available reports32,33 suggest that small tumor
size permits easier removal and a lower incidence of
operative complications, particularly cranial nerve
injuries. Davidge-Pitts and Pantanowitz26 showed a
positive correlation between the size of the tumor
and the Shamblin classification as determined intra-
operatively. In their study, tumors 4 cm or greater in
diameter more commonly encircled the carotid
arteries either partially (Shamblin class 2) or com-
pletely (class 3). In our series, when Group I and
Group II tumors were compared with regard to
Shamblin classification, no class 3 tumors were
found among the smaller Group II tumors. The sur-
gical procedure appeared to have been technically
easier in Group II; neither internal carotid artery
reconstruction nor external carotid artery ligation
were necessary in any Group II patient (Table II).
Our series also showed that more neurologic com-
plications were observed in the group of patients
with larger tumors. Actually, the one cranial nerve
injury observed in Group II occurred during
removal of a 4 · 3-cm chemodectoma that despite
its size had been missed on clinical examination and
was first detected on duplex scan. All nerve injuries
occurred in chemodectomas that were at least 4 cm
in diameter.
The discovery of small tumors on imaging stud-
ies sometimes creates a dilemma: should a very small
tumor be resected or not? A 0.9 · 0.5-cm tumor was
detected by duplex scanning in the present study.
Because of the patient’ s age (77 years) and the size
of the lesion, it was elected to treat her conserva-
tively with annual duplex surveillance. Farr32 has
estimated the growth rate of these lesions at about
0.5 cm per year. In view of the relative slow growth
of these lesions, it may be feasible to follow selected
patients with duplex scanning at 6-month to 12-
month intervals.
The routine use of preoperative tumor emboliza-
tion has been questioned because of the potential
neurologic complication associated with the acci-
dental reflux of particulate matter into the oph-
thalmic or cerebral circulation.31 Some authors
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advocate its use before the resection of large tumors
because it may decrease the vascularity of the tumor,
reducing9,34 intraoperative blood loss and transfu-
sion requirements. This adjunctive procedure was
successfully performed in 5 of 6 cases in Group I,
with a mean tumor size of 5 cm. The remaining
patient sustained an ipsilateral stroke during
embolization. Although the surgeons using preoper-
ative embolization commented that blood loss was
reduced, in fact only one patient in the study
received a blood transfusion. We believe that the
apparent benefits of embolization should be
weighed against the risk of stroke and that its cur-
rent use be limited to tumors greater than 5 cm in
diameter. The early detection and resection of small-
er lesions therefore appears to provide an additional
advantage by decreasing the need for preoperative
embolization and its attendant risks.
Another unresolved therapeutic issue is the benefi-
ciality of radiotherapy on these tumors. Radiotherapy
has been used in patients with metastatic lesions or
lesions presumed to be malignant. Although some
reports35,36 have indicated that such tumors were
radioresistant, other reports5 have shown that radio-
therapy can result in regression of these tumors in
some instances; however, after initial control, recur-
rence has been observed.8 The only patient treated by
adjuvant radiation therapy in our series later manifest-
ed local recurrence and regional metastasis.
CONCLUSION
The rationale for aggressive surgical excision of
CBTs was initially based on early data suggesting
that up to 50% of these paragangliomas were malig-
nant. The subsequent recognition that these lesions
were slow-growing and rarely malignant and that
surgical therapy was often associated with local (cra-
nial nerve) complications led some authors to rec-
ommend careful observation of these lesions. Recent
series advocate resection of all tumors once they are
discovered in appropriate patients. The increasing
use of newer imaging modalities, particularly duplex
scanning, may allow earlier detection of CBTs and
hence safer operations. The eight patients whose
CBTs were detected by imaging modalities had the
same morality rate (0%) as, and a lower incidence of
cranial nerve injury than, those patients whose
tumors had been detected clinically. Furthermore no
patient in the former group required external carotid
artery ligation or internal carotid artery replace-
ment. Duplex scanning may be used to follow tumor
growth in poor-risk patients with small tumors,
although this algorithm remains unproven.
The authors thank Drs. D.J. Green, M. Yamamura, M.
Gooden, and Cindy Leudke for their assistance in collect-
ing the data; Dr. Scott Berman for the statistical analysis;
Dr. John Hughes for editorial assistance; and Dr. J. Kelly
for contributing a case.
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Dr. Ralph B. Dilley (San Diego, Calif.). I congratulate
Dr. Westerband and his colleagues for a nice presentation
and for reviewing a large series of patients with carotid
body tumors, which were treated in a contemporary time
frame. As the authors indicate, some series in the literature
studied more patients with these rare tumors, but these
reports spanned more years and most often treated the
patients without the benefit of modern techniques of eval-
uation and management.
The major thrust of the presentation is that if these
tumors are discovered early, when small, then, resection is
accomplished without the known high incidence of oper-
ative stroke or, more particularly, cranial nerve damage.
The authors divided patients into two groups. The
first group consisted of tumors discovered when a neck
mass prompted evaluation; the second consisted of
patients with tumors discovered by an imaging technique,
which was used to investigate other conditions, most often
the question of carotid artery disease. The results lend
support to the view that all tumors should be resected,
particularly when small, because the incidence of neuro-
logic complications are fewest when small tumors were
resected. In this series, 5 of 23 patients had neurologic
complications when operations were performed for clini-
cally evident tumors. Only 1 patient in 8 had a neurolog-
ic complication when tumors were discovered by an imag-
ing technique and were not clinically evident. In all cases
with neurologic complications, the size of the tumor
exceeded 4 cm.
The authors also indicate important principles in the
modern management of these tumors. These include the
following principles: the role of duplex scanning in diag-
nosis and screening; the role of computed tomography
scanning or magnetic resonance imaging if there is a ques-
tion of multiplicity; the necessity for preoperative neuro-
logic assessment, particularly cranial nerve function; the
importance of preparing the thigh for a vein graft if the
tumor is large or it is suspected that the tumor encom-
passes the internal carotid artery (known as Shamblin
Type III tumors); the importance of the use of a bipolar
cautery to avoid heat injury to nerves; and finally, details
of dissection including the necessity of dissection in the
adventitial plane for larger tumors.
In spite of these generally accepted principles of man-
agement, there remain several controversial areas. This fact
prompts the following questions:
1. Because carotid body tumors generally are recog-
nized to be familial, do you recommend screening
relatives of patients with these lesions? Which rela-
tives would you screen?
2. Is duplex scanning for anatomic detail accurate
enough so that angiography is not necessary? All of
your patients but one had both duplex scan studies
and angiography.
3. When do you believe preoperative embolization is
indicated? Is this indicated on the basis of size of
the tumor? If so, what size justifies preoperative
embolization? Although most reports of stroke
during preoperative embolization are anecdotal,
they recur with disturbing frequency. You experi-
enced one episode in your series. On the other
hand, the availability of small tracking catheters for
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selective catheterization of feeding vessels should
considerably decrease the risk of stroke. So, when
should we consider preoperative embolization?
4. You used carotid shunts in three patients and yet
reconstructed the carotid artery in eight patients.
When do you use a carotid shunt? Do you measure
pressure stump to guide this decision?
5. Finally, you suggest that some small tumors may be
followed before operative intervention. At what
size would you recommend resection?
I enjoyed this paper and appreciate the opportunity
for discussion.
Dr. Alex Westerband. I thank Dr. Dilley for his review
of our manuscript and for his thoughtful comments.
In answer to the first question, most chemodectomas
appear sporadically in about 70% to 80% of the cases.
However, there are some familial cases, and in these cases,
it has been shown that bilaterality is common.
Should we scan the relatives of patients with carotid
body tumors? I do not have any strong data to support
that suggestion, but I would tend to say yes. Brothers and
sisters should be screened for the presence of carotid body
tumor, especially if they have a small lump in the neck.
Is duplex scanning accurate enough? I believe duplex
scanning is certainly accurate enough to make a diagnosis
of carotid body tumors. One of the typical findings on
duplex scan is low arterial resistance of the flow pattern
within the carotid body tumors.
To my knowledge, there is no neoplasm other than a
carotid body tumor that occurs in the carotid bifurcation.
For a small tumor that is 2 cm or less in size, a duplex scan
alone probably can establish the diagnosis well enough to
proceed with the resection.
Your third question asked when to perform preopera-
tive embolization. According to the literature, advocates
of preoperative embolization require a tumor that mea-
sures 3 cm or larger. Obviously, there is a risk attached to
performing the preoperative embolization. Because of this
risk, some authors do not recommend embolization at all.
In answer to your fourth question, a shunt was used in
only three patients. Those patients had a mean age of 48
years, therefore, we did not measure the back pressure.
Many of them were young, between 30 and 50 years of
age.
Your last question asked what size tumor to resect. We
should resect all tumors unless the tumor is small and the
patient has coexisting medical conditions that would
increase operative risks.
Dr. Tammy Ramos (Omaha, Neb.). I enjoyed your
review, Dr. Westerband. We recently reviewed our experi-
ence at the University of California at San Francisco over
a contemporary 10-year period to assess whether preoper-
ative embolization was necessary. There were 23 patients
in our review. Of those patients, 11 had preoperative
embolization and 12 did not. The median tumor size was
4 to 5 cm in this group of patients. We found no differ-
ence in outcome with respect to operative technique,
blood loss, and time in those two groups of patients. The
only significant difference that we found was in length of
hospitalization. The length of stay was longer in the group
that was embolized.
Dr. Westerband. Thank you for your comments.
